QFR vs FFR: Understanding Intermediate Coronary Stenosis
Table of Contents
As of July 2025, the landscape of interventional cardiology is continually shaped by advancements in diagnostic technologies. Among these, quantitative flow ratio (QFR) has emerged as a significant growth, earning a Class 1B suggestion from the European Society of Cardiology. This endorsement highlights its growing importance in clinical practise. Though, the recent findings from the FAVOR III Europe trial have introduced a crucial discussion point: can QFR truly serve as a definitive substitute for the established gold standard, fractional flow reserve (FFR), notably when FFR is readily accessible? This article delves into the comparative strengths and limitations of QFR and FFR, exploring their roles in contemporary cardiac interventions and the ongoing quest for superior diagnostic tools.
Understanding the Foundations: FFR and the Physiology of Coronary Artery Disease
Fractional flow reserve (FFR) has long been the benchmark for assessing the hemodynamic meaning of coronary artery stenoses. It is indeed defined as the ratio of the maximum achievable myocardial blood flow in a stenotic coronary artery to the maximum achievable blood flow in the same artery without the stenosis. This physiological measurement is typically obtained during hyperemia, induced by intravenous adenosine, and involves invasive pressure wire measurements.
The Invasive Gold Standard: how FFR Works
The process of performing FFR involves a cardiac catheterization procedure. A pressure sensor-equipped guidewire is advanced across the lesion of interest. Together, a reference sensor is placed in the aorta.During maximal hyperemia, the ratio of the distal coronary pressure to the aortic pressure is calculated. An FFR value of less than 0.80 is generally considered indicative of a hemodynamically significant stenosis, suggesting that the narrowing is likely to impede blood flow sufficiently to cause ischemia.
Why FFR Matters: Clinical Implications
The widespread adoption of FFR has revolutionized the management of coronary artery disease. By providing a physiological assessment, it helps interventional cardiologists differentiate between anatomical stenoses that are visually significant but functionally irrelevant, and those that truly warrant revascularization. This approach has been shown to improve patient outcomes, reduce needless stenting, and optimize treatment strategies, ultimately leading to better long-term results and reduced healthcare costs.
The Rise of QFR: A Non-Invasive Alternative?
Quantitative flow ratio (QFR) represents a significant technological leap, aiming to provide similar physiological insights without the need for invasive pressure wire measurements. It leverages advanced computational fluid dynamics and artificial intelligence applied to routine angiographic imaging.
The Mechanics of QFR: From Angiography to Physiology
QFR analysis begins with the acquisition of standard coronary angiograms. These images are then processed by sophisticated software that reconstructs a 3D model of the coronary artery. using this model, the software simulates blood flow dynamics, calculating the pressure gradients across stenotic lesions. Crucially, QFR can be performed both at baseline and during hyperemia, often simulated computationally rather than induced invasively. The ratio of distal to proximal pressure during hyperemia is then calculated, mirroring the FFR measurement.
Advantages of QFR: Speed, Accessibility, and Reduced Risk
the primary allure of QFR lies in its potential to streamline the diagnostic process. By eliminating the need for an invasive pressure wire and the administration of hyperemic agents like adenosine, QFR offers several key advantages:
Reduced Procedure Time: The absence of pressure wire manipulation and the need for adenosine infusion can significantly shorten the overall catheterization procedure time.
Lower Risk Profile: Avoiding invasive pressure measurements inherently reduces the procedural risks associated with guidewire manipulation, such as coronary artery dissection or perforation.
Cost-Effectiveness: While initial software investment is required, the elimination of disposable pressure wires and adenosine can lead to cost savings per procedure.
Enhanced Accessibility: QFR’s reliance on existing angiographic equipment makes it potentially more accessible in centers that may have limited resources for invasive pressure wire technology.
The FAVOR III Europe Trial: A Critical Examination of QFR’s Role
The FAVOR III Europe trial, a landmark study in this field, has provided crucial data regarding the comparative performance of QFR and FFR. The trial’s findings have been instrumental in shaping the current understanding of QFR’s place in clinical practice.
Key Findings and Their Implications
The FAVOR III Europe trial compared the outcomes of patients treated based on QFR guidance versus those treated based on FFR guidance. While the trial demonstrated that QFR could be performed successfully and that its results were largely concordant with FFR, it also highlighted crucial considerations. The trial’s results suggest that while QFR can be a valuable tool, it may not be a straightforward substitute for FFR when FFR is readily available and the expertise for its performance is present.
The implication here is that the clinical decision-making process, particularly